| Joseph Michael Seguel, MD | |
|
2 New Hampshire Ave, Troy, NY 12180-1762 | |
| (518) 272-0331 | |
| Not Available |
| Full Name | Joseph Michael Seguel |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 18 Years |
| Location | 2 New Hampshire Ave, Troy, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962652867 | NPI | - | NPPES |
| 03625138 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 271179 (New York) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 271179 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Samaritan Hospital | Troy, NY | Hospital |
| St Peter's Hospital | Albany, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St. Peter's Health Partners Medical Associates, P.c. | 6103061189 | 393 |
News Archive
Scientists from the University of Oxford and the Ludwig Institute for Cancer Research are building on the success of the Oxford-AstraZeneca vaccine against SARS-CoV-2 to develop a vaccine to treat cancer.
Today is an exciting day for men with advanced prostate cancer and the millions of families and loved ones who are profoundly affected. Today a new prostate cancer treatment option, Provenge, was approved by the Food and Drug Administration.
Clumps of proteins that accumulate in brain cells are a hallmark of neurological diseases such as dementia, Parkinson's disease and Alzheimer's disease. Over the past several years, there has been much controversy over the structure of one of those proteins, known as alpha synuclein.
A vaccine that induces immune responses to a wide spectrum of influenza virus strains and subtypes has produced strong and durable results in early-stage clinical trials in humans, Mount Sinai researchers have found.
› Verified 8 days ago
| Entity Name | Samaritan Hospital Of Troy, New York |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043267727 PECOS PAC ID: 6507770070 Enrollment ID: O20031118000782 |
News Archive
Scientists from the University of Oxford and the Ludwig Institute for Cancer Research are building on the success of the Oxford-AstraZeneca vaccine against SARS-CoV-2 to develop a vaccine to treat cancer.
Today is an exciting day for men with advanced prostate cancer and the millions of families and loved ones who are profoundly affected. Today a new prostate cancer treatment option, Provenge, was approved by the Food and Drug Administration.
Clumps of proteins that accumulate in brain cells are a hallmark of neurological diseases such as dementia, Parkinson's disease and Alzheimer's disease. Over the past several years, there has been much controversy over the structure of one of those proteins, known as alpha synuclein.
A vaccine that induces immune responses to a wide spectrum of influenza virus strains and subtypes has produced strong and durable results in early-stage clinical trials in humans, Mount Sinai researchers have found.
› Verified 8 days ago
| Entity Name | St. Peter's Health Partners Medical Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750626834 PECOS PAC ID: 6103061189 Enrollment ID: O20130321000567 |
News Archive
Scientists from the University of Oxford and the Ludwig Institute for Cancer Research are building on the success of the Oxford-AstraZeneca vaccine against SARS-CoV-2 to develop a vaccine to treat cancer.
Today is an exciting day for men with advanced prostate cancer and the millions of families and loved ones who are profoundly affected. Today a new prostate cancer treatment option, Provenge, was approved by the Food and Drug Administration.
Clumps of proteins that accumulate in brain cells are a hallmark of neurological diseases such as dementia, Parkinson's disease and Alzheimer's disease. Over the past several years, there has been much controversy over the structure of one of those proteins, known as alpha synuclein.
A vaccine that induces immune responses to a wide spectrum of influenza virus strains and subtypes has produced strong and durable results in early-stage clinical trials in humans, Mount Sinai researchers have found.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Michael Seguel, MD Po Box 14890, Albany, NY 12212-4890 Ph: (518) 525-5634 | Joseph Michael Seguel, MD 2 New Hampshire Ave, Troy, NY 12180-1762 Ph: (518) 272-0331 |
News Archive
Scientists from the University of Oxford and the Ludwig Institute for Cancer Research are building on the success of the Oxford-AstraZeneca vaccine against SARS-CoV-2 to develop a vaccine to treat cancer.
Today is an exciting day for men with advanced prostate cancer and the millions of families and loved ones who are profoundly affected. Today a new prostate cancer treatment option, Provenge, was approved by the Food and Drug Administration.
Clumps of proteins that accumulate in brain cells are a hallmark of neurological diseases such as dementia, Parkinson's disease and Alzheimer's disease. Over the past several years, there has been much controversy over the structure of one of those proteins, known as alpha synuclein.
A vaccine that induces immune responses to a wide spectrum of influenza virus strains and subtypes has produced strong and durable results in early-stage clinical trials in humans, Mount Sinai researchers have found.
› Verified 8 days ago
Samuel Anameze, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2215 Burdett Ave, Troy, NY 12180 Phone: 518-270-3094 Fax: 518-270-3095 | |
Mr. Christopher Jon Huyck, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2414 15th St, Troy, NY 12180 Phone: 518-271-1813 Fax: 518-271-1931 | |
Mustafain Y Meghani, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2001 5th Ave, Suite 110, Troy, NY 12180 Phone: 518-687-1960 Fax: 518-687-1970 | |
Dr. Pierrot Jeannot, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 147 Hoosick St Ste K, Troy, NY 12180 Phone: 518-268-5370 | |
Dennis Mckevitt, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2215 Burdett Ave, Troy, NY 12180 Phone: 518-272-0331 Fax: 518-271-9007 | |
Martin P Echt, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2231 Burdett Ave, Ste 160, Troy, NY 12180 Phone: 518-292-6200 Fax: 518-292-6228 | |
Shitaye Argaw, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2215 Burdett Ave, Troy, NY 12180 Phone: 518-270-3094 Fax: 518-270-3095 |